Related StoriesAmyloid PET method is effective for detecting early signals of Alzheimer's diseaseExperimental drug candidate aimed at combating Alzheimer's disease has anti-aging effectsMore analysis needed before recommending antidepressants, Alzheimer's disease medicines for stroke recovery: Research By leveraging our combined resources and proficiency, we believe we are able to speed up the discovery and advancement of new drugs for Alzheimer's disease and advantage tens of millions of people potentially, says Howard Fillit, MD, Founding Executive Chief and Director Technology Officer in the ADDF. Our funded researchers will benefit from an unprecedented degree of drug discovery guidance as well as access to Pfizer's advancement experience. The collaboration, which grew out of a 2011 meeting at Faster Cures Partnering for Cures conference, can be representative of the raising part of cross-sector collaboration in the medication discovery process.Dr. Mary Daly, seat of medical genetics at Fox Chase Cancer tumor Center in Philadelphia, called the reduced rate of genetic counseling ‘concerning.’ Such counseling is vital that you help the implications be comprehended by a female of the test, especially since the dropping cost of genetic testing means that doctors often order a test that covers dozens of genes. ‘We’re no longer just doing a test for BRCA. We’re doing a panel as high as 25 different genes,’ Daly said. ‘Which makes the interpretation of the results that a lot more difficult.’ But only one from every 20 ladies in this scholarly study came back positive for a BRCA mutation, which raises the question of whether the other 19 women received any benefit at all of the from the guidance they got beforehand, Narod said.